Project Grant HT94252310188

Award Date 9/30/23
Completion Date 9/29/26
Dollars Obligated $749K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Richmond, VA 23284, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded a $623,003 Project Grant to Virginia Commonwealth University (VCU) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from May 1, 2024 to April 30, 2027, will fund a longitudinal study to characterize the genetic architecture and risk factors for post-concussive symptoms, post-traumatic stress disorder, and alcohol use disorder in a military cohort. VCU has subawarded a portion of the grant to...
This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $249,732 in funding to Virginia Commonwealth University (VCU) for research on novel kappa opioid receptor (KOR) agonists and their potential to promote central nervous system (CNS) repair. The award, which runs from September 1, 2024 to August 31, 2025, will enable VCU to conduct research aimed at developing effective treatments for...
The University of Virginia received a three-year, $775,153 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research investigating TBI-induced disruption of brain drainage as a mechanistic driver of AD pathogenesis. Through this award, the University will support basic, applied, and advanced biomedical research aimed at transforming military and public health care by investigating medical solutions...
The Defense Health Agency awarded a $3,995,791 project grant to Virginia Commonwealth University under the Military Medical Research and Development program (CFDA 12.420) to compare the attentional demands and functional outcomes of pattern recognition and direct myoelectric control in people with transradial amputation. VCU will conduct this research from September 2023 through September 2027 in Richmond, Virginia. Two subawards were also provided. Hanger Institute for Clinical Research and...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $751,038 to Virginia Commonwealth University (VCU) to conduct research on the use of ketone ester intravenous infusion as a new treatment for traumatic brain injury. The award period runs from September 30, 2024 to September 29, 2027. VCU, a public research university in Richmond, Virginia, has extensive experience supporting federal healthcare and biomedical...
The Department of Defense's Defense Health Agency awarded Virginia Commonwealth University (VCU) a $568,461 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "READING HISTONE H2A UBIQUITINATION IN THE FUNCTION OF RSF1 IN BREAST CANCERS WITH RSF1 GENE AMPLIFICATION." The grant, effective from March 1, 2024 through February 28, 2027, will fund VCU's research to advance the scientific understanding of breast cancer and develop...
The Virginia Commonwealth University will receive $1.5 million over four years from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to manage distress in malignant brain cancer. Through this Project Grant award issued on August 1, 2021 and concluding on July 31, 2025, VCU will provide services to transform healthcare for service members and the public through innovative research investigating medical solutions for the...
This $5,954,349 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support a randomized controlled trial to optimize heart rate variability in combat veterans and service members with persistent post-concussion symptoms. The prime awardee, Virginia Commonwealth University, will collaborate with sub-awardees Palo Alto Veterans Institute For Research and Richmond Institute For Veterans Research to conduct this...
Virginia Commonwealth University was awarded a two-year, $232,875 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research titled "GLT-1/EAAT2: A NOVEL PLAYER IN MYELIN REPAIR" being conducted between September 30, 2022 and September 29, 2024 in Richmond, Virginia. Through this funding, VCU researchers will investigate medical solutions for the battlefield by exploring the...
This Project Grant from the Defense Health Agency provides $745,381 to Virginia Commonwealth University from June 1, 2023 through May 31, 2026 to support research on "POST-TRAUMATIC EPILEPTOGENESIS: ROLE OF NEOCORTICAL-HIPPOCAMPAL INTERACTIONS" under the Military Medical Research and Development program (CFDA 12.420). VCU will conduct this research to advance the program's goals of transforming military and public healthcare through innovative biomedical research solutions. Subawards...

Virginia Commonwealth University was awarded a $749,446 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to develop a novel TNF inhibitor to improve outcomes in a mouse model of traumatic brain injury. Through supporting innovative biomedical research, the Military Medical Research and Development program aims to transform military and public health care by investigating medical solutions applicable to battlefield medicine. This award will support VCU's work developing new treatment approaches for traumatic brain injuries.

Generated 1/6/24, 9:59 AM